farmakologi toksikologi i

18
FARMAKOLOGI TOKSIKOLOGI I ROBERT TUNGADI

Upload: rifkaanggai

Post on 27-Apr-2015

31 views

Category:

Documents


1 download

DESCRIPTION

9okj8ih76

TRANSCRIPT

Page 1: Farmakologi Toksikologi i

FARMAKOLOGI TOKSIKOLOGI IROBERT TUNGADI

Page 2: Farmakologi Toksikologi i

DASAR-DASAR FARMAKOLOGI TOKSKOLOGI topical topical

(ear) (eye)nasal inhalation

oralbuccalSublingual

Topical skin IV injection

Rectal / vagina

subcutan / IM injection

intra-articular injection

Figure 2.1 Sites of drug administration

Page 3: Farmakologi Toksikologi i

ABSORPSION OF DRUGS

Whatever the route of administration, a drug must reach its site of action.

In order to do this, the drug will have to cross several cell membranes to reach the blood (unless it is injected intravenously).

The three ways by which substances, including drugs, can cross cell membranes are simple diffusion, facilitated diffusion and active transport.

Page 4: Farmakologi Toksikologi i

DIFFUSION

Several factors are known to influence the diffusion of substances across the cell membrane:

• the membrane must be permeable to the substance in question;

• there must be a concentration gradient;• the molecular size/weight of the substance

must be small enough;• a large surface area is necessary for efficient

diffusion;• a short distance is necessary for efficient

diffusion.

Page 5: Farmakologi Toksikologi i

MEMBRANE TRANSPORT MECHANISM

(a) simple diffusion (b) facilitated diffusion (c) active transport

Page 6: Farmakologi Toksikologi i

SIMPLE DIFFUSION

Simple diffusion of drug molecules depends mostly on lipid solubility.

The structure of the cell membrane can be a barrier to diffusion of drugs because it is essentially a lipid bilayer with proteins embedded in the inner and outer surfaces.

Lipid-soluble substances diffuse easily through the lipid bilayer and include oxygen, carbon dioxide, fatty acids, steroids and fat-soluble vitamins.

The lipid solubility of a drug depends on its state of ionization.

Page 7: Farmakologi Toksikologi i

FACILITATED DIFFUSION

Many nutrients and a few drugs can pass across the cell membrane by facilitated diffusion.

In this case, in addition to the concentration gradient, a membrane protein acts as a carrier to transport a substance from one side of the membrane to the other.

Carrier proteins are specific and only transport molecules that they ‘recognize’.

Glucose enters many body cells by facilitated diffusion and the process appears to be more efficient than simple diffusion.

Page 8: Farmakologi Toksikologi i

ACTIVE TRANSPORT

Active transport involves a carrier protein but differs from diffusion in two important ways. Cellular energy in the form of ATP (adenosine triphosphate) is required to drive the process and transport goes against the concentration gradient.

Active transport mechanisms are particularly important in the transport of ions, nutrients and neurotransmitters and may be involved in the transport of some drugs.

Page 9: Farmakologi Toksikologi i

DRUG DISTRUBUTION When a drug is administered, it does not achieve an equal

concentration throughout the body. Unless a drug is injected directly into the blood stream it

will be absorbed from its site of administration, then enter the systemic circulation and be transported to the tissues in plasma.

The body can be considered to be made up of aqueous and lipid compartments.

Lipid compartments include all cell membranes and adipose tissue.

Aqueous compartments include tissue fluid, cellular fluid, blood plasma and fluid in places like the central nervous system, the lymphatic system, joints and the gastrointestinal tract.

The distribution of a drug into these different compartments depends on many factors.

Page 10: Farmakologi Toksikologi i

AQUEOUS SOLUBILITY

Aqueous solubility affects distribution because water-soluble drugs have difficulty crossing cell membranes and therefore tend to remain in the circulation.

Consequently, water-soluble drugs are not well distributed throughout the body.

They exist in large amounts in the plasma or tissue fluid and are rapidly cleared by the liver or kidney.

In practice, such drugs have little therapeutic use.

Page 11: Farmakologi Toksikologi i

BLOOD FLOW

At equilibrium, drugs are partitioned between plasma, plasma proteins and the different tissues.

The rate of distribution to different tissues depends largely on the rate of blood flow through them.

Some areas of the body have a relatively good blood supply, for example, the major organs; muscles and skin have a moderate supply; and bone and adipose tissue have a poor supply. Thus, major organs receive a relatively high concentration a drug whereas it can be difficult to get drugs into less well-perfused areas.

Page 12: Farmakologi Toksikologi i

PLASMA PROTEIN BINDING A large number of drugs have a high affinity for albumin and other

plasma proteins. Binding to plasma protein inhibits distribution outside the blood

since only unbound drug will be further distributed. Plasma protein binding therefore reduces active drug concentration

and ultimate response to the drug. Drugs can compete for the same protein binding sites and this is a

form of drug interaction. A well-known and important example is that of warfarin and aspirin. Warfarin is an anticoagulant, which binds extensively to plasma

proteins, and this is taken into account when dosages are worked out.

Aspirin taken with warfarin competes for the same protein binding sites, which means that they each displace the other and the amount of free drug in the plasma is increased for both drugs.

Patients stabilized on warfarin should never take aspirin because the effect of increased free plasma concentration of warfarin can be severe haemorrhaging.

Page 13: Farmakologi Toksikologi i

LIPID SOLUBILITY

Lipid-soluble drugs enter cells readily. Distribution of such drugs is widespread unless plasma protein binding is extensive.

Elimination of lipid-soluble drugs is usually slow because clearance from plasma via the kidneys removes only a small proportion of the drug in any given time.

Page 14: Farmakologi Toksikologi i

TISSUE SEQUESTRATION Considerable amounts of drug may be stored in certain

tissues, particularly fat and muscle. Sequestration in this way gives an apparent large volume

of distribution but also means that only a small proportion of total drug concentration will reach its site of action.

This can create difficulties with the usage of certain drugs. For example, general anaesthetics are highly lipid-soluble

drugs. Sequestration into adipose tissue can make anaesthetizing

obese people hazardous because it is difficult to control the amount of free drug in the circulation.

Similarly, benzodiazepines (antianxiety drugs) can be difficult to clear from the body because they are stored in large amounts in adipose tissue.

Page 15: Farmakologi Toksikologi i

CONTINUE

For example, griseofulvin has an affinity for keratin. Since this drug can be used to treat fungal infections of the skin and nails its sequestration into keratin is something of an advantage.

The antibiotic tetracycline has an affinity for bones and teeth. It should never be used in children as its accumulation can damage teeth and stunt growth.

Page 16: Farmakologi Toksikologi i

METABOLISM AND EXCRETION

The rate at which a drug is metabolized will affect its distribution.

Similarly the rate of elimination or excretion also affects distribution and vice versa.

Page 17: Farmakologi Toksikologi i

VOLUME OF DISTRIBUTION Volume of distribution is a concept that describes the

body compartments into which a drug could be distributed.

If a drug is water soluble it is likely to remain in the blood stream and its volume of distribution will be relatively small and equal blood volume.

Similarly, acidic drugs tend to bind to plasma albumin and therefore also remain in the blood stream and have a small volume of distribution.

If a drug is highly lipid soluble, then it will be distributed to many parts of the body and have a large volume of

distribution. In addition, basic drugs tend to bind to tissue proteins

and as a result have a large volume of distribution.

Page 18: Farmakologi Toksikologi i

DRUG METABOLISM